Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 March
Sonoma Pharmaceuticals, Inc. has filed 974 SEC EDGAR filings since 15 Jan 2002

SEC filing history

Showing 626-650 of 746 matching filings.

Per page
25
Current page
26
10-Q File 001-33216

QUARTERLY REPORT

Filing date
03 Aug 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT ON FORM 8-K

Filing date
02 Aug 2012
Reporting date
02 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
30 Jul 2012
Reporting date
27 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33216

PROXY STATEMENT

Filing date
27 Jul 2012
Reporting date
11 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

OCULUS 8-K

Filing date
27 Jun 2012
Reporting date
21 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-182263

OCULUS INNOVATIVE SCIENCES, INC.

Filing date
21 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8K

Filing date
21 Jun 2012
Reporting date
18 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
07 Jun 2012
Reporting date
07 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT ON FORM 8-K

Filing date
25 May 2012
Reporting date
21 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
25 Apr 2012
Reporting date
22 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171411

PROSPECTUS SUPPLEMENT

Filing date
24 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84019

OCLS 13G 04.24.12

Filing date
24 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Mar 2012
Reporting date
07 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Mar 2012
Reporting date
07 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

OCULUS INNOVATIVE SCIENCES, INC.

Filing date
07 Mar 2012
Reporting date
06 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
10 Feb 2012
Reporting date
07 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171411

FORM 424B5

Filing date
08 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT ON FORM 8-K

Filing date
02 Feb 2012
Reporting date
02 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jan 2012
Reporting date
12 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

8-K filing

Filing date
28 Dec 2011
Reporting date
22 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171411

424B5 filing

Filing date
27 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-177462

FORM 424B3

Filing date
05 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-177462

EFFECT filing

Filing date
02 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .